Category

• Pipeline2
• Business1

Organizations

• Bausch + Lomb64
• Alcon, Inc.43
• Eyes On Eyecare43
• American Optometric Association34
• Harrow28
• Glaukos26
• Regeneron22
• Topcon Healthcare22
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• Cataract Surgery3
• Clinical Trials3
• Acquisitions1
• Cataract1
• Patient Care1
• Surgery1

• Organizations: Melt Pharmaceuticals✕

Clear all

Business

Harrow to purchase Melt Pharmaceuticals

Key draw is the company’s patented oral tablet formulated for a sublingual delivery to provide rapid sedation and analgesia ahead of cataract surgery.

Pipeline

Melt reports favorable phase 3 data on preop procedural sedation tablet

Topline findings demonstrate statistically superior performance of non-IV, non-opioid tablet during cataract surgery.

Pipeline

First patient dosed in phase 3 study on needle- and opioid-free sedation for cataract surgery

Melt Pharmaceuticals’ rapid-dissolving tablet intends to offer greater patient comfort during sedation without the need for needles or opioids.